Neurogene stops Batten gene therapy after FDA denies request, dealing double dose of bad news Read more 

Incyte's $750M buyout rocked by pause on key trial, asset cull Read more 

Nearing potential FDA approval, BridgeBio shows additional positive data on ATTR-CM candidate acoramidis Read more 

LSI Europe 25 Emerging Medtech Summit

LSI has successfully hosted nine global summits to date—six in Southern California and three across Europe—attracting over 10,000 global executives. Unlike many events that lack [...]

Go to Top